Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Thromboxane beta 2:MCnc:Pt:Ser/Plas:Qn

Known as: Thromboxane beta 2 [Mass/volume] in Serum or Plasma, Thromboxane bêta 2:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique, Thromboxane bêta 2:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif 
 
National Institutes of Health

Related topics

Related topics

7 relations
Chemical procedurePlasSerumThromboxane B2
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
The intrahelical salt bridge between E/D3.49 and R3.50 within the E/DRY motif on helix 3 (H3) and the interhelical hydrogen… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2012
2012
Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries.
  • B. Liu, W. Luo, +4 authors Y. Zhou
  • American journal of physiology. Renal physiology
  • 2012
    • Corpus ID: 22527066
This study aimed to determine whether PGI(2) would be evoked by the endogenous endothelial B(2) receptor agonist bradykinin (BK… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
Brain-penetrant tetrahydronaphthalene thromboxane A2-prostanoid (TP) receptor antagonists as prototype therapeutics for Alzheimer's disease.
A hallmark pathological feature of the Alzheimer's disease (AD) brain is the presence of senile plaques, which comprise amyloid… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
2011
2011
Cyclopentane-1,3-dione: a novel isostere for the carboxylic acid functional group. Application to the design of potent thromboxane (A2) receptor antagonists.
Cyclopentane-1,3-diones are known to exhibit pK(a) values typically in the range of carboxylic acids. To explore the potential of… Expand
2007
2007
Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
INTRODUCTION Platelets in vivo react under low-shear venous-flow as well as high-shear arterial-flow conditions. Because most… Expand
2007
2007
Thromboxane A 2 is a key regulator of pathogenesis during Trypanosoma cruzi infection
JEM © The Rockefeller University Press $15.00 Vol. 204, No. 4, April 16, 2007 929–940 www.jem.org/cgi/doi/10.1084/jem.20062432… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
Effects of the COX-2 Inhibitor FK3311 on Ischemia—Reperfusion Injury in the Rat Lung
Ischemia–reperfusion injury is induced by activation of the arachidonic acid cascade following the induction of cyclooxygenase-2… Expand
Review
2007
Review
2007
NV-52
NV-52, a synthetic flavonoid derivative, is a selective thromboxane synthase (TXS) inhibitor that is being developed as a… Expand
Highly Cited
2002
Highly Cited
2002
In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model
Prostanoids formed by cyclooxygenase play an important role in pain and the induction of inflammation. It is generally believed… Expand
2000
2000
Underexpression of neural cell adhesion molecule and neurotrophic factors in rat brain following thromboxane A(2)-induced intrauterine growth retardation.
Intrauterine growth retardation (IUGR) often results in clinical neurodevelopmental disorders. To clarify the influence of… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE